![]() CIRS CIRS (also known as Computerized Imaging Reference Systems) is a company that manufactures tissue equivalent phantoms and simulators intended to improve upon existing tissue simulation methodology. | ![]() Viewpoint Molecular Targeting Viewpoint Molecular Targeting is a radiopharmaceutical company that develops alpha-particle therapy for cancer. | Curasight Curasight is a company engaged in the field of exploiting a Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (uPAR). | |||
Founding Date | Founding Date 1982 | Founding Date 2008 | Founding Date 2013 | Founding Date 2003 | Founding Date 2014 |
Type | Type Private | Type Subsidiary | Type Private | Type Subsidiary | Type Subsidiary |
Tags | |||||
Locations | Locations Norfolk, US HQ | Locations Coralville, US HQ | Locations København, DK HQ | Locations Bundoora, AU HQ München, DE Hummelstown, US | Locations Oxford, GB HQ Dublin, IE Burlington, US |
Employees | Employees 254% decrease | Employees 517% decrease | Employees 7 | Employees 20 | Employees 1061% decrease |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised $ 300k | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 19.7m |

Viewpoint Molecular Targeting is a radiopharmaceutical company that develops alpha-particle therapy for cancer.
View companyCurasight is a company engaged in the field of exploiting a Positron Emissions Tomography (PET) imaging platform targeting the urokinase-type plasminogen activator receptor (uPAR).
View company
vivoPharm is a company that provides preclinical oncology and immuno-oncology services.
View company
Blue Earth Diagnostics is a molecular imaging diagnostics company.
View company